atorvastatin has been researched along with leupeptins in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adeli, K; Dulay, D; Macri, J; Mohammadi, A; Newton, R; Romain, T | 1 |
Balligand, JL; Desager, JP; Dessy, C; Feron, O | 1 |
2 other study(ies) available for atorvastatin and leupeptins
Article | Year |
---|---|
Effects of atorvastatin on the intracellular stability and secretion of apolipoprotein B in HepG2 cells.
Topics: Albumins; Anticholesteremic Agents; Apolipoproteins B; Atorvastatin; Cell Membrane Permeability; Cholesterol; Cholesterol Esters; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracellular Fluid; Leupeptins; Multienzyme Complexes; Oleic Acid; Proteasome Endopeptidase Complex; Pyrroles; Tumor Cells, Cultured | 1998 |
Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance.
Topics: Animals; Atorvastatin; Cattle; Caveolin 1; Caveolins; CCAAT-Enhancer-Binding Proteins; Cells, Cultured; Cholesterol; Cholesterol, LDL; Cysteine Proteinase Inhibitors; DNA-Binding Proteins; Dose-Response Relationship, Drug; Endothelium, Vascular; Heptanoic Acids; HSP90 Heat-Shock Proteins; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leupeptins; Lipoproteins, LDL; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Pyrroles; Sterol Regulatory Element Binding Protein 1; Transcription Factors; Up-Regulation | 2001 |